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1 These authors contributed equally to this work.Hepatitis B viral X protein (HBx) is a multifunctional transactivator and implicated in hepatitis B
virus (HBV) replication and hepatocarcinogenesis. HBx can be ubiquitinated and degraded through
ubiquitin-proteasome pathway. However, the E3 ubiquitin ligase regulating HBx ubiquitin-depen-
dent degradation is still unknown. In this study, we identiﬁed Siah-1 as a novel E3 ubiquitin ligase
for HBx, which interacted with HBx and facilitated HBx poly-ubiquitylation and proteasomal degra-
dation. Co-expression of Siah-1 attenuated the transcriptional transactivation of HBx on glucocorti-
coid response element (GRE), heat shock response element (HSE) and cAMP response element (CRE)
signal pathways. Moreover, Siah-1 participated in p53-mediated HBx degradation. Therefore, Siah-1
may play important roles in ubiquitin-dependent degradation of HBx and may be involved in sup-
pressing the progression of hepatocellular carcinoma (HCC).
Structured summary of protein interactions:
SIAH1 and HBx colocalize by ﬂuorescence microscopy (View interaction)
SIAH1 physically interacts with HBx by anti tag coimmunoprecipitation (View interaction)
HBx physically interacts with SIAH1 by anti tag coimmunoprecipitation (View interaction)
SIAH1 binds to HBx by pull down (View interaction)
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Hepatocellular carcinoma (HCC) is a common malignancy and
chronic hepatitis B virus (HBV) infection is one of the major risks
of developing HCC, which accounts for more than 80% of HCC cases
in high-incidence region [1]. The pathogenesis and carcinogenesis
of HBV-associated HCC mainly involve continuous liver inﬂamma-
tion response to virus infection and the integration of HBV DNA
into the host genome to induce direct mutagenesis of diverse can-
cer-related genes [2]. In many cases of HCC, the hepatitis B  gene
is commonly integrated among the HBV genes. Hepatitis B viral X
protein (HBx) can associate with many proteins to transactivate achemical Societies. Published by E
titis B viral X protein; HCC,
associated herpesvirus; GRE,
sponse element; CRE, cAMP
itin; aa, amino acid
enetic Engineering, Institute
nghai 200433, PR China. Fax:variety of viral and cellular genes, and affect gene transcription,
intracellular signal transduction, genotoxic stress response, protein
degradation, cell cycle control and apoptosis [3]. Comprehensive
studies have suggested that HBx is a promiscuous transactivator
and is involved in HBV replication and hepatocarcinogenesis
[4,5]. A high incidence of HCC was observed in transgenic mice
expressing HBx protein [6,7] and knock-down of HBx expression
in Hep3B cells markedly reduced xenograft tumor growth [8].
Therefore, HBx expression level is crucial in the pathogenesis of
HCC.
The stability of HBx protein is regulated in vivo. HBx can be
actively ubiquitinated and undergo proteolysis through the
ubiquitin-proteasome pathway [9]. It has been discovered that
26S proteasome complex [9], heat shock protein 40 (Hsp40) [10],
HBV core proteins [11], tumor suppressor p53 [12], transcriptional
factor Id-1 [13] and MDM2 [14] contribute to destabilizing HBx
protein in a proteasome-dependent manner. However, no speciﬁc
E3 ubiquitin ligase(s) accounted for ubiquitylation-dependent
proteasomal degradation of HBx protein has been identiﬁed until
now. Id-1 has been demonstrated to destabilize HBx protein by
facilitating the interaction between ubiquitinated HBx andlsevier B.V. All rights reserved.
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ubiquitylation modiﬁcation of HBx [13]. Tumor suppressor p53 is
capable of increasing HBx ubiquitylation with an unknown mech-
anism [14]. Our present study attempts to search for the speciﬁc E3
ubiquitin ligase that mediates HBx ubiquitylation and degradation.
The Siah-1/2 are the mammalian homologues of Drosophila Se-
ven in absentia (Sina) protein [15]. The N-terminus of Siah mem-
bers encoding Ring-ﬁnger domain can associate with ubiquitin
conjugating enzymes (E2s), conferring Siah proteins the E3 ubiqui-
tin ligase activity; and the C-terminal regions are the substrate-
binding domain (SBD) that can interact with various proteins,
some of which can be degraded [16]. Siah-1 and Siah-2 are two hu-
man Siah members, which are highly conserved and have some
overlapping functions. Through mediating the cellular proteins
for ubiquitin-proteasome degradation, Siah-1/2 are involved in di-
verse biological processes, including apoptosis [17,18], mitosis
[19], estrogen signaling [20], Ras pathway [21,22], hypoxia [23],
DNA damage [24], etc. Siah-1/2 can form dimer with itself or their
homologues and regulate their own availability via self ubiquityla-
tion and degradation [16]. Additionally, Siah-1 may act in a com-
plex with Skp1, Eb1, SIP and pAPC to promote b-catenin for
ubiquitin-mediated degradation, which may reduce malignant cell
proliferation and oncogenesis [25,26]. Recent study found that
ORF45 protein encoded by Kaposi’s sarcoma-associated herpesvi-
rus (KSHV) was also the substrate of Siah-1, implicating Siah-1 as
a modulator of virus infection [27].
In this study, we identiﬁed Siah-1 as a novel E3 ligase to pro-
mote HBx poly-ubiquitylation and proteasomal degradation. More-
over, p53-mediated HBx reduction was also dependent on Siah-1
expression. Therefore, our ﬁndings suggest that Siah-1 may play
an important role in HBx degradation via ubiquitin-dependent
pathway and may be involved in suppressing the progression of
HCC.2. Materials and methods
2.1. Cell culture and transfection
Hep3B cells were cultured in RPMI 1640, 293T and HepG2 cells
were grown in Dulbecco’s modiﬁed Eagle’s medium (DMEM) at
37 C in 5% CO2-humidiﬁed atmosphere. Both mediums were sup-
plemented with 10% fetal bovine serum (FBS). Hep3B and HepG2
cells are two human HCC cell lines, and Hep3B is deﬁcient in p53
expression whereas HepG2 cell has wild type p53 expression. Cells
at 80% conﬂuency were transfected with plasmids using Lipofect-
amine2000™ reagent (Invitrogen) according to manufacturer’s
instructions.
2.2. Plasmids and antibodies
pCMV-Myc-HBx was kindly provided by Dr. Minghua Zhu
(Changhai Hospital, the Second Military Medical University of Chi-
na). HBx cDNA was subcloned into pcDNA3.1b() (Invitrogen) and
pET-32a-His vectors (Novagen). The cDNA encoding human Siah-1
and Siah-2 were PCR ampliﬁed from human liver marathon cDNA
library, and subcloned into PCMV-Myc vector (Clontech). Catalyti-
cally inactive mutant Siah-1-C44S were generated using TaKaRa
Mutagenesis Kit. The wild type and mutant were also introduced
into pCMV-HA (Clontech) and pGEX-4T-2 vectors (Amersham Bio-
sciences) for expressing HA and GST fusion protein, respectively.
The glucocorticoid response element (GRE), cAMP response ele-
ment (CRE) and heat shock response element (HSE)-luc constructs
were purchased from Clontech.
Speciﬁc antibodies used in this paper were as follows: anti-HBx,
anti-GFP and DO-1 for anti-p53 (Santa Cruz, USA), anti-Siah-1(Abcam, USA), anti-HA (Convance, USA), anti-Myc and anti-b-Actin
(Sigma, USA), anti-GST and anti-His (Novagen, Germany).
2.3. 3RNA interference and siRNA transfection
The RNAi oligos were purchased from Genepharma (Shanghai,





The RNAi oligos sequences for p53 are:
50-GACUCCAGUGGUAAUCUACdTdT-30;
The RNAi oligos for negative control are:
50-AACUCCUGCCUCCUUAUGUAUUUdTdT-30;
The siRNA oligos were transfected using the Lipofectamine™
2000 reagent (Invitrogen, USA) as described below. Diluted 1 ll
Lipofectamine™ 2000 and 50 ll Opti-MEM were mixed gently
and incubated for 5 min at room temperature. Then, 20 pmol siR-
NA oligos and the corresponding co-transfected plasmids were di-
luted in 50 ll Opti-MEM. After 5-min incubation, the diluted oligos
and plasmids with the diluted Lipofectamine™ 2000 were mixed
gently and incubated for 20 min before adding the complexes to
each well. The effect of gene knockdown was detected by Western
blot.
2.4. Western blot, luciferase reporter assay and immunoprecipitation
These experiments were performed as described previously
[14].
2.5. GST pull-down assay
GST-Siah-1, His-HBx and four His-HBx constructs were ex-
pressed in E. coli, and puriﬁed according to the manufacture’s pro-
tocol (Amersham Pharmacia Biotech).
2.6. Immunoﬂuorescence staining
Hep3B cells cultured on coverslips were ﬁxed in PBS with 4%
paraformaldehyde and permeabilized in 0.2% Triton X-100. The
coverslips were blocked with 5% normal goat serum plus 2% BSA,
and then incubated with mouse anti-Myc monoclonal antibody
or rabbit anti-HA polyclonal antibody, respectively. We then
sequentially incubated the coverslips with goat anti-mouse-Alexa
555 secondary antibody or the Alexa Fluor 488 goat anti-rabbit
IgG secondary antibody, and with DAPI. All images were acquired
using a LEICA DC 500 camera microscope equipped with LEICA
DMRA2 ﬂuorescent optics.
2.7. In vivo ubiquitylation assay
The ubiquitylation assay in vivo was performed by transfecting
293T cells in 6-well with 300 ng pGFP–N3, 400 ng HA-ubiquitin,
4 lg pcDNA3.1b()His-HBx and together with 6 lg Myc-Siah-1
or Myc-Siah-1-C44S plasmids as indicated. The pcDNA3.1b()vec-
tor was used to keep equal amounts of plasmid DNA in each trans-
fection. Twenty hours later the cells were treated with proteasome
inhibitor MG132 (30 lM) for 6 h and then lysed in buffer A (6 M
guanidinium-HCl, 0.1 M Na2HPO4/NaH2PO4, 0.01 M Tris–HCl pH
8.0, 5 mM imidazole, 10 mM b-mercaptoethanol) and incubated
with Ni2+-NTA beads for 4 h at room temperature. Beads were
washed with buffer A, B (8 M urea, 0.1 M Na2HPO4/NaH2PO4,
0.01 M Tris–HCl pH 8.0, 10 mM b-mercaptoethanol) and C (8 M
urea, 0.1 M Na2HPO4/NaH2PO4, 0.01 M Tris–HCl pH 6.3, 10 mM b-
mercaptoethanol), and bound proteins were eluted with buffer D
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b-mercaptoethanol, 5% SDS) and analyzed by Western blot.3. Result
3.1. Siah-1 induces HBx protein degradation via proteasome pathway
and attenuates the transcriptional transactivation of HBx
HBx protein can be modiﬁed by poly-ubiquitylation and de-
graded rapidly through ubiquitin-proteasome pathway in vivo
[9–13]. However, E3 ubiquitin ligase responsible for HBx ubiqui-
tin-dependent degradation is unknown. Tumor suppressor p53
can increase HBx ubiquitylation and promote HBx degradation
with unknown mechanism [12]. Considering that p53 is a tran-
scriptional activator but not E3 ubiquitin ligase itself, p53 can de-
grade proteins by inducing E3 ubiquitin ligases expression. For
example, p53 destabilizes the p21WAF1 by inducing the expression
of Ring-ﬁnger E3 ubiquitin ligase p53RFP [28]. Siah-1 has been re-
ported to be a p53-inducible E3 ubiquitin ligase [17,25,26], and the
expression of Siah-1 was downregulated in advanced HCC [29].
Moreover, Siah-1 is capable of mediating herpesvirus-encoded
ORF45 protein for ubiquitin degradation [27]. Therefore, we inves-
tigated whether Siah-1 was one of the candidate E3 ubiquitin li-
gases for the ubiquitin-dependent degradation of viral protein
HBx. To verify the role of Siah-1 in HBx degradation, we also con-
structed a Siah-1 mutant with cysteine-to-serine substitution at
codon 44 in its N-terminal Ring domain (Siah-1-C44S). Previous
studies have reported that the Siah-1-C44S mutant abrogated the
E3 ubiquitin ligase activity of Siah-1 to promote substrate DCC
degradation and rapid self-degradation, and may have dominant
negative effect on endogenous Siah-1 [16,22].
In Hep3B HCC cells (p53 defective), we found that HBx protein
level was signiﬁcantly reduced in a dose-dependent manner when
coexpressed with Siah-1 but not with the catalytically inactive mu-
tant Siah-1-C44S (Fig. 1A). Additionally, the other homologue Siah-
2 also had similar impact on the reduction of HBx protein level
(Fig. 1B), while another p53-inducible Ring-domain E3 ubiquitin li-
gase Pirh2 had no effect on HBx stability (Fig. 1C). These results
indicated that Siah-1/2 has potential regulatory effect on HBx pro-
tein level and the ubiquitin ligase activity of Siah-1 was required
for this process. Because of the high similarity in structure and
function between Siah-1 and Siah-2 [15], our present study only
focused on Siah-1. Moreover, treatment with proteasome inhibitor
MG132 could rescue HBx reduction mediated by Siah-1 (Fig. 1D),
indicating that Siah-1 decreased HBx level in a proteasome-depen-
dent manner. Meanwhile, knockdown of endogenous Siah-1 by
two speciﬁc siRNA resulted in higher HBx protein level compared
with the control (Fig. 1E), further supporting that HBx protein is
down-regulated by Siah-1.
To further demonstrate that Siah-1 regulated HBx abundance at
post-translational level, we also determined the effects of Siah-1
and the Siah-1-C44S mutant on HBx protein turnover. The relative
stability of the HBx protein was examined at the indicated interval
after treatment with cycloheximide (CHX) to block protein synthe-
sis. As shown in Fig. 1F, coexpression of Siah-1 accelerated HBx
protein degradation. In contrast, HBx was stabilized by the Siah-
1-C44S mutant, perhaps because the Siah-1-C44S mutant may
act as a dominant negative mutant abrogating the activity of
endogenous Siah-1.
Moreover, co-expressed Siah-1 attenuated the glucocorticoid
response element (GRE), heat shock response element (HSE), cAMP
response element (CRE) signal pathways transactivated by ectopi-
cally expressed HBx, while these signal pathways were not affected
by Siah-1 over-expression alone (Fig. 1G). This implied that HBx-
mediated oncogenic signals could be inhibited by Siah-1.Thus, the above results suggest that E3 ubiquitin ligase Siah-1
promotes the proteasomal degradation of HBx protein in vivo
and counteracts HBx transactivation activity.
3.2. Siah-1 interacts with HBx in vivo and in vitro
Siah-1 carries out the E3 ubiquitin ligase function by directly
or indirectly interacting with substrates [16,25]. Accordingly we
employed a co-immunoprecipitation assay to investigate whether
Siah-1 interacted with HBx in vivo. HA-Siah-1 and Myc-HBx were
transfected into 293T cells alone or in combination. Cells were
treated with the proteasome inhibitor MG132 for 6 h to maintain
the proteins levels before harvest. As shown in Fig. 2A, when
immunoprecipitated with anti-HA antibody, Myc-HBx was de-
tected in the co-immunoprecipitated complex from cells co-
transfected with HA-Siah-1 (Fig. 2A, middle panel), and consis-
tent result was observed in a reciprocal experiment by using
anti-Myc antibody (Fig. 2A, right panel). Meanwhile, we found
the Siah-1-C44S mutant also retained the ability to interact with
HBx (Fig. 2B). Further, GST pull-down result conﬁrmed that His-
HBx directly interacted with GST-Siah-1 but not GST tag in vitro
(Fig. 2C).
To verify the interaction between Siah-1 and HBx in vivo, we
further investigated whether Siah-1/Siah-1-C44S mutant and HBx
proteins colocalized in the same subcelluar compartment via
immunoﬂuorescence analyses. HA-Siah-1/HA-Siah-1-C44S mutant
and Myc-HBx were transfected alone or in combination, into
Hep3B cells. Immunoﬂuorescence analysis (Fig. 2D) showed that
Myc-HBx alone was mainly detected in cytoplasm at the periphery
of the nuclear envelope, and HA-Siah-1 and HA-Siah-1-C44S mu-
tant alone predominantly exhibited the punctuated cytoplasmic
staining. The co-expressed HBx and wild type Siah-1 colocalized
in cytoplasm with a perinuclear distribution at the small speckle
patterns; the HBx and Siah-1-C44S mutant also appeared to have
the speckle colocalization distribution in the cytoplasm. These
ﬁndings provided further evidence to support the interaction be-
tween HBx and Siah-1 in vivo.
To delineate the Siah-1-interacting domain within HBx protein,
four His-HBx truncation mutants were constructed (Fig. 2E, left
panel). GST pull-down assay indicated that His-HBxD2,D3,D4 mu-
tant maintained similar capability of binding to GST-Siah-1 as full
length one, but D1 mutant failed to do so (Fig. 2E, right panel).
This result suggested the central transactivation domain of HBx
[51–136 amino acid (aa)] is indispensable for the interaction with
Siah-1.
3.3. Siah-1 facilitates poly-ubiquitylation of HBx
Siah-1 has been conﬁrmed to catalyze the poly-ubiquitylation
of most substrates. HBx protein could be actively ubiquitinated
and both ubiquitin-dependent and -independent proteasomal
degradation were operative in its turnover [30]. To determine
whether Siah-1 affected HBx poly-ubiquitylation modiﬁcation,
we performed an in vivo ubiquitylation assay. As shown in Fig. 3,
a strong smear of HBx poly-ubiquitylation bands was detected
when co-expressed with Myc-Siah-1, but a much weaker smear
band of HBx was observed in the presence of Myc-Siah-1-C44S,
suggesting ubiquitin ligase activity is essential for HBx poly-
ubiquitylation.
3.4. p53-mediated HBx degradation depends on Siah-1 expression
Tumor suppressor p53 was reported to promote HBx ubiquity-
lation and destabilized HBx protein [12]. The p53-inducible E3
ubiquitin ligase MDM2 has been found to promote HBx proteaso-
mal degradation, but it is unable to induce HBx ubiquitylation
Fig. 1. Siah-1 induces HBx protein degradation via the proteasomal pathway and attenuates transactivation activity of HBx. (A–C) Siah-1 reduced HBx protein level. Hep3B
cells were co-transfected with constant amount of Myc-HBx plasmid and with increasing amounts of Myc-Siah-1, Myc-Siah-1-C44S mutant, Myc-Siah-2, or Myc-Pirh2. Thirty
six hours after transfection, Western blot was performed with antibodies as indicated. The pGFP–N3 expression plasmid was used as an internal control for transfection
efﬁciency. (D) Siah-1-mediated HBx reduction was proteasome-dependent. The transfected cells as above were treated with 30 lM MG132 or DMSO for 6 h. (E) Myc-HBx
plasmids were co-transfected with either siRNA control or siRNA speciﬁc for Siah-1 into 293T, Hep3B and HepG2 cells, Western blot was performed as indicated while b-Actin
was used as the loading control. (F) Siah-1 accelerated HBx protein turnover. Myc-HBx was co-transfected with pCMV-Myc empty vector, Myc-Siah-1, or Myc-Siah-1-C44S
into Hep3B. 24 h after transfection, cells were treated with 40 lM CHX for indicated interval, followed by Western blot. The graph showed the quantiﬁcation of the remaining
HBx level by standardization to GFP using software Quantity One (Version 4.4.1) from three independent experiments. (G). Siah-1 attenuated the transactivation activity of
HBx. Reporter plasmids GRE, HSE or CRE was co-transfected with the indicated plasmids. Data represent the mean values ± SD (n = 3).
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tional target. Therefore, we speculated that p53-mediated HBx pro-
tein ubiquitylation and degradation might depend on Siah-1
induction. Therefore, we conﬁrmed that wild type p53 inducedendogenous Siah-1 expression, whereas the transcriptionally inac-
tive mutant p53 R249S had impaired inducing effect on Siah-1
expression (Fig. 4A). Moreover, depletion of endogenous p53
protein level by siRNA in HepG2 (p53 wild type) cells increased
J. Zhao et al. / FEBS Letters 585 (2011) 2943–2950 2947the HBx level as previously reported [12], and simultaneously re-
duced Siah-1 expression (Fig. 4B). In Hep3B cells (p53 defective),
HBx decreased signiﬁcantly when transfected with p53 (Fig. 4C,Fig. 2. Siah-1 interacts with HBx in vivo and in vitro. (A) Siah-1 and HBx interacted w
plasmids either alone or together, treating cells with the proteasome inhibitor MG132 fo
panel) or anti-Myc (right panel) antibodies and then analyzed by Western blot with ant
mutant and Myc-HBx was performed as above, but without treatment with MG132. (C) S
proteins were immobilized on resin and incubated with the puriﬁed His-HBx for 3 h be
were stained with mouse monoclonal anti-Myc antibody to detect HBx followed by gre
antibody to detect Siah-1 or Siah-1-C44S followed by incubation with red ﬂuorescence-co
ﬂuorescence micrographs were shown as above. (E) Mapping the Siah-1-interacting do
truncated mutants with His tag. Right panel showed the pull-down results.lane 2). However, HBx protein level was increased in response to
Siah-1 knockdown even when p53 was exogenously expressed
(Fig. 4C, lane 3).ith each other in vivo. 293T cells were transfected with Myc-HBx and HA-Siah-1
r 6 h before harvesting. Cell lysates were immunoprecipitated with anti-HA (middle
i-HA or anti-Myc antibody as indicated. (B) The interaction between HA-Siah-C44S
iah-1 and HBx interacted with each other in vitro. The puriﬁed GST and GST-Siah-1
fore extensive wash. (D) HBx and Siah-1 co-localized in the cytoplasm. Hep3B cells
en ﬂuorescence-conjugated secondary antibody and with rabbit polyclonal anti-HA
njugated secondary antibody. Nuclei were stained with DAPI (Blue). Overlays of the
main within HBx protein. Left panel was the schematic representation of four HBx
2948 J. Zhao et al. / FEBS Letters 585 (2011) 2943–2950Taken together, these results demonstrated that the p53-in-
duced Siah-1 expression participates in p53-mediated HBx
degradation.Fig. 3. Siah-1 facilitates poly-ubiquitylation of HBx. 293T cells were transfected
with plasmids encoding HA-ubiquitin, His-HBx and HA-Siah-1 or HA-Siah-1-C44S.
Twenty four hours after transfection, cells were treated with MG132 for 6 h. Cell
lysates were prepared and His-HBx was pulled down under denaturing conditions
with Ni-NTA beads. Eluted proteins were detected by Western blot with anti-HA
antibody. The whole cell lysates were analyzed for protein expression (lower
panels). GFP was used to control for transfection efﬁciency.4. Discussion
Genomic integration of the HBx gene is highly frequent in HBV-
infected HCC cases, and overexpression of HBx protein closely cor-
relates with the progression of HCC [3]. HBx protein can be actively
ubiquitinated and subjected to degradation through ubiquitin-pro-
teasome pathway. In this study, we ﬁrst identiﬁed Siah-1 as a novel
E3 ubiquitin ligase for HBx. Unlike those proteins which only in-
duced proteasome-dependent degradation of HBx protein in an
indirect manner [9–13], Siah-1 could directly facilitate the poly-
ubiquitylation of HBx. Additionally, Siah-1 could stimulate the
degradation of KSHV-encoded ORF45 protein which is implicated
in virus infection and replication [27,31]. Similar to ORF45, HBx
was involved in establishing HBV replication and hepatocarcino-
genesis [4,5]. Therefore, we inferred that Siah-1 may play impor-
tant roles in ﬁghting virus infection and may be involved in the
HCC pathogenesis.
Meanwhile, we found that HBx could transactivate the heat
shock transcription factors (HSFs) mediated signaling pathway,
which is crucial for enhancing the expression of heat shock pro-
teins. The elevated expressions of Hsp90, Hsp70 and Hsp27 can
promote cell growth, proliferation, anti-apoptosis, and are associ-
ated with high-grade malignant tumors [32]. It is noteworthy that
Siah-1 could effectively abrogate HBx-induced elevation of HSE
and other signaling pathway. Additionally, Siah-1 expression has
been found to be down-regulated in HCC samples [29]. Hence,
we hypothesize that the reduction of Siah-1 may facilitate HBx
protein to exert its pleiotropic effects. This also provides new evi-
dence that down-regulation of Siah-1 correlates with larger, poorly
differentiated and/or advanced staged HCC [29].
The inhibition of tumor suppressor p53 by HBx has been exten-
sively studied. HBx can bind to p53 directly, sequestering p53 pro-
tein in the cytoplasm and preventing its entry into nucleus.
Thereby, HBx can suppress p53 sequence-speciﬁc DNA binding,
transcriptional activity, p53-mediated apoptosis and disrupt the
association between p53 and other proteins, such as the nucleotide
excision repair factors XPB/ERCC3 and XPD [33]. We hypothesized
that Siah-1 may be important in ﬁghting with HBV infection by
degrading HBx at the early stage of virus infection. Recent studies
reported that p53 could increase HBx ubiquitylation and stimulate
HBx protein degradation [12]. Whereas HBV in host would induce
dysfunctional p53 mutation, and the interaction between p53 and
HBx would abrogate p53 function. The inhibition of p53 function
may result in the low expression of Siah-1. Siah-1 downregulation
may facilitate HBV replication at the latter stage of virus infection.
Our previous study also found that HBx protein was rarely detect-
able in HCC samples with wild type p53 status and p53-induced E3
ubiquitin ligase MDM2 could decrease HBx protein level [14]. Nev-
ertheless, we inferred that MDM2 may not be the only effector
responsible for HBx stability. One reason is that MDM2 has no
inﬂuence on HBx ubiquitylation [14]; more importantly, MDM2
protein level is up-regulated in HCC and over-expression MDM2
correlates with poor prognosis [34]. Our present study demon-
strated that wild type p53 but not mutant p53 could induce
Siah-1 expression and that E3 ubiquitin ligase Siah-1 participated
in p53-mediated HBx ubiquitylation and degradation. Thus, our
ﬁndings suggest that highly frequent dysfunctional p53 mutation
in HCC may be one reason for Siah-1 down-regulation, which
may be one possible mechanism for p53 mutation causing up-
regulation of HBx protein level in HCC. p53-mediated HBx
degradation through the Ub-dependent pathway by Siah-1 orUb-independent pathway by MDM2 may be linked to different
physiological environments and different subcellular localization
of HBx. Here, we found Siah-1 co-localized with HBx in the
cytoplasm. HBx was also reported to localize in mitochondria
[35] and nucleus [36].
Siah proteins contain an important binding groove that recog-
nizes a peptide motif PXAXVXP, within many substrates and adapt-
ors [37]. Although the full-length HBx lacks similar motif, our
ﬁndings demonstrated that Siah-1 and HBx interacted both
in vitro and in vivo. Moreover, truncated HBx containing the only
middle transactivating domain (51–136 aa) still maintained the
binding capacity to Siah-1. It is also known that damaged-DNA
binding complex (DDB1) could bind to HBx within the middle do-
main (60–101 aa), and protect HBx from proteasome-dependent
degradation [38]. Thus, the possible competitive association with
HBx in the similar region between Siah-1 and DDB1 may be an-
other regulatory manner for HBx stability.
In conclusion, our results demonstrate that Siah-1 is a novel
negative regulator for HBx stability and facilitates the ubiquityla-
tion of HBx. Furthermore, Siah-1 can inhibit the transcriptional
ability of HBx and participates in p53-mediated HBx degradation.
Therefore, our ﬁndings shed new light on why down-regulation
of Siah-1 and p53 mutation may lead to development and progres-
sion of HCC.
Fig. 4. p53-induced Siah-1 participates in p53-mediated HBx reduction. (A) p53 induced Siah-1 expression. Increasing amount pCMV-p53 or mutant pCMV-p53-R249S
plasmids were transfected into Hep3B, then Western blot was performed and b-Actin was used as control. (B) The siRNA control or siRNA speciﬁc for p53 were co-transfected
with Myc-HBx plasmids into HepG2 cells, followed by Western blot. (C) In Hep3B cells, the equal amount pCMV-Myc-HBx plasmids were co-transfected along with siRNA
control and pCMV-Myc-p53, or along with siRNA Siah-1 and pCMV-Myc-p53 as indicated in (C). Western blot detected the p53 and HBx protein levels with anti-Myc
antibody, Siah-1 levels were determined with anti-Siah-1 antibody. b-Actin is used as control. The bar graphs on the right showed the corresponding relative protein levels by
standardization to Actin as indicated. Data was shown as mean ± SD, n = 3.
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